Find clinical trials for Non-Hodgkin Lymphoma in Barcelona, CT
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Hodgkin Lymphoma trials near Barcelona, CT, ESP:
ARV-393 in patients diagnosed with advanced Relapsed/Refractory non-Hodgkin's lymphoma (R/R NHL) to determine if ARV-393 m-...
Phase 1
Barcelona, Spain and 16 other locations
The primary objective of this study is to characterize the safety and tolerability of loncastuximab tesirine in combination with polatuzumab vedotin,...
Phase 1
Barcelona, Spain and 41 other locations
The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-99282 alone and in combination with anti-lymphoma...
Phase 1, Phase 2
Barcelona, Spain and 68 other locations
immunogenicity, pharmacokinetics and pharmacodynamics of IKS03, a CD19 targeting antibody-drug conjugate, in patients with advanced B cell non...
Phase 1
Badalona, Spain and 12 other locations
in patients with relapsed or refractory aggressive B-cell Non-Hodgkin Lymphomas (B-NHLs).The study has 2 parts. The aim of...
Phase 1
Barcelona, Spain and 19 other locations
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (a white blood cell responsible for fighting infections). The purp-...
Phase 2
Barcelona, Spain and 76 other locations
The goal of the study is to assess the safety and anti-lymphoma activity of MEN1703 (Dapolsertib hydrochloride) when given as a single-agent-...
Phase 2
Barcelona, Spain and 35 other locations
of differentiation (CD)19 in pediatric patients with relapsed or refractory (r/r) B cell acute lymphoblastic leukemia (B ALL) and r/r B cell Non...
Phase 1
Barcelona, Spain and 7 other locations
of adult participants with relapsed or refractory (r/r) B-Cell non-Hodgkin lymphoma (B-NHL) or frontline high-risk diffuse...
Phase 1, Phase 2
Barcelona, Spain and 31 other locations
additional open-label imaging feasibility sub-study using a tracer in adult participants with relpased/refractory B-cell non-Hodgkin...
Phase 1, Phase 2
Barcelona, Spain and 18 other locations
Clinical trials
Research sites
Resources
Legal